Sektor Perspective Therapeutics, Inc.

Aktien

A40EDR

US46489V3024

CATX

Biotechnologie

Markt geschlossen - NYSE 22:00:00 08.07.2026 % 5 Tage Veränd. 1. Jan.
3.390 USD -0.88% Intraday Chart für Perspective Therapeutics, Inc. -0.59% +23.27%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
-0.88%-0.59%+11.88%-22.43%+23.27%-2.59%-48.01%-55.45%-59.88% 390 Mio.
-0.24%+4.98%+18.00%+13.92%+6.55%+2.69%+9.14%-15.64%+256.12% 49.74 Mrd.
-0.36%+1.33%+27.17%+97.08%+138.25%+417.51%+619.10%+512.16% - 40.49 Mrd.
-2.29%+5.93%+11.77%-0.64%-0.64%+25.27%+59.26%-4.20%+947.83% 34.35 Mrd.
-2.13%+5.47%+11.09%+19.44%-9.59%+25.45%-6.01%-19.75%+195.39% 34.75 Mrd.
-0.79%+2.02%+3.15%-4.16%+2.56%+3.83%+36.42%-19.31%+151.10% 26.98 Mrd.
+3.82%+3.92%+31.71% - - - - - - 16.58 Mrd.
-2.62%+0.45%+17.11%+4.62%-5.28%+66.82%+125.87%+198.47% - 15.6 Mrd.
-2.17%+6.52%+13.40%+14.31%+6.76%+102.15%+102.15%+116.79%+235.96% 14.27 Mrd.
-2.70%-2.19%+3.30%+3.11%+7.47%+11.25%+18.19%-32.60%+103.83% 13.76 Mrd.
-1.93%-4.74%+10.72%+54.41%-9.19%+12.11%-30.02%-24.37%+133.15% 12.92 Mrd.
-3.71%+5.71%+38.99%+22.65%+1.41%+1’695.59%+667.92%+319.59%+2’766.20% 12.49 Mrd.
-2.06%-1.25%+23.50%+32.10%+12.27%+45.52%+8.25%-41.55%+165.04% 11.01 Mrd.
+0.50%+0.44%+36.49%+31.82%+20.66%+37.69%-12.18%-38.79%+146.45% 11 Mrd.
-4.69%-1.14%+23.35%+22.33%-3.01%-1.28% - - - 10.79 Mrd.
-0.22%+0.39%+53.30%+60.00%+76.54%+239.58% - - - 10.01 Mrd.
-4.26%-0.44%+54.00%+34.15%+46.72%+160.58%+407.83%+118.36% - 9.81 Mrd.
-1.68%+3.62%+26.85%+64.42%+94.03%+85.73%+81.69%+112.99%+13.01% 9.2 Mrd.
+2.79%-0.54%+31.10%+8.58%+12.98%+613.35%+1’749.94%+15.02% - 9.03 Mrd.
-0.55%+14.27%+43.84%+35.01%+60.37%+180.87%+504.79%+210.10% - 9.06 Mrd.
Durchschnitt -1.12%+3.46%+24.53%+25.83%+25.38%+195.90%+252.61%+79.52%+421.18% 17.61 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung -1.09%+4.01%+21.09%+27.79%+26.06%+166.01%+206.51%+95.06%+436.40%
Biotechnologie und medizinische Forschung - Andere
  1. Börse
  2. Aktien
  3. A40EDR Aktie
  4. Sektor Perspective Therapeutics, Inc.